Vaneck Pharmaceutical ETF (PPH)

$90.00 +0.60 (0.67%)
Market Cap N/A
Revenue (ttm) N/A
Net Income (ttm) N/A
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 106,427
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts N/A
Price Target N/A

Company Profile

The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.

Phone: 888-658-8287
StocktwitsNews
StocktwitsNews Feb. 23 at 11:31 AM
Merck Is Reportedly Splitting Its Pharma Division As Keytruda Patent Nears 2028 Expiry $MRK $PPH $PJP $IYH https://stocktwits.com/news/equity/markets/merck-splitting-pharma-division-keytruda-patent-nears-2028-expiry/cZRt85ZR4yE
0 · Reply
chuckieclam
chuckieclam Feb. 23 at 10:16 AM
$NVO $PPH $PVAL $VKTX
0 · Reply
StocktwitsNews
StocktwitsNews Feb. 23 at 9:55 AM
Why Is NVO Stock Falling Pre-Market Today? $NVO $PPH $PVAL $AVDE $FTHI https://stocktwits.com/news/equity/markets/why-is-nvo-stock-falling-pre-market-today/cZRtZlKR4UC
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 20 at 1:13 AM
$PPH Current Stock Price: $110.95 Contracts to trade: $111.0 PPH Feb 20 2026 Call Entry: $0.35 Exit: $0.48 ROI: 38% Hold ~25 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 18 at 9:40 PM
$PPH RSI: 71.14, MACD: 1.8078 Vol: 2.11, MA20: 108.30, MA50: 105.08 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
StocktwitsNews
StocktwitsNews Feb. 12 at 10:21 AM
Novo Looks To Ireland To Scale Production Of Wegovy Pill: Report $NVO $OZEM $PPH https://stocktwits.com/news/equity/markets/novo-looks-to-ireland-to-scale-production-of-wegovy-pill-report/cZRT0F6R4rc
0 · Reply
TalkMarkets
TalkMarkets Feb. 9 at 8:08 PM
Wild Week Of Rotation: Sector Performance 2026 $PPH $SPY $XBI $XLV $ARKG https://talkmarkets.com/content/etfs/wild-week-of-rotation-sector-performance-2026?post=556147
0 · Reply
StocktwitsNews
StocktwitsNews Feb. 9 at 4:21 PM
FDA Says Novo's Wegovy Pill TV Advertisement Is Misleading: NVO Stock Pares Gains $NVO $HIMS $PPH $PVAL $AVDE https://stocktwits.com/news/equity/markets/fda-novo-wegovy-pill-tv-advertisement-misleading-nvo-stock-pares-gains/cZbv5uwR4oX
1 · Reply
StocktwitsNews
StocktwitsNews Feb. 9 at 12:42 PM
Why Did IINN Stock Surge 28% In Pre-Market Today? $IINN $PPH $IHE https://stocktwits.com/news/equity/markets/why-did-iinn-stock-surge-in-pre-market-today/cZbHzC8R4oP
0 · Reply
weqwewqeq1111
weqwewqeq1111 Feb. 9 at 12:37 PM
$NVO $HIMS $PPH $PVAL $AVDE
0 · Reply
Latest News on PPH
Big Pharma's Earnings Week: Strong Performance, Obesity Wars, LOE Management And More

Feb 7, 2026, 8:30 AM EST - 16 days ago

Big Pharma's Earnings Week: Strong Performance, Obesity Wars, LOE Management And More

IYH XLV XPH

Novo Nordisk's Wegovy Pill Shakes Up Rivalry With Eli Lilly, Puts Health Care ETFs In Focus

Dec 23, 2025, 2:04 PM EST - 2 months ago

Novo Nordisk's Wegovy Pill Shakes Up Rivalry With Eli Lilly, Puts Health Care ETFs In Focus

NVO IBB VHT XBI

Why PPH Keeps Working When Single Themes Break

Dec 17, 2025, 3:35 PM EST - 2 months ago

Why PPH Keeps Working When Single Themes Break

Britain will spend more on new medicines in exchange for avoiding tariffs on U.K. pharmaceutical exports to the U.S.

Dec 1, 2025, 1:33 PM EST - 2 months ago

Britain will spend more on new medicines in exchange for avoiding tariffs on U.K. pharmaceutical exports to the U.S.

XPH

Ozempic—and 14 other popular prescription drugs—will cost less for Medicare after the U.S. government negotiated lower prices

Nov 25, 2025, 6:24 PM EST - 3 months ago

Ozempic—and 14 other popular prescription drugs—will cost less for Medicare after the U.S. government negotiated lower prices

PJP

3 Best Healthcare Stocks: Quant Strong Buys From Goldman's 'Alpha' List

Nov 17, 2025, 4:05 PM EST - 3 months ago

3 Best Healthcare Stocks: Quant Strong Buys From Goldman's 'Alpha' List

INCY PFE VRTX XBI XLV

Investing In Health Stocks - How Policy Clarity Is Opening Doors

Nov 11, 2025, 10:13 AM EST - 3 months ago

Investing In Health Stocks - How Policy Clarity Is Opening Doors

AGNG ARKG BBC BBH BBP BIB BIS

Final Trade: JCI, PPH, TOL, IBM

Oct 7, 2025, 6:19 PM EDT - 4 months ago

Final Trade: JCI, PPH, TOL, IBM

IBM JCI TOL

Drug Tariffs Are a Sideshow. Trump's Next Move Could Hit Pharma Harder.

Sep 27, 2025, 5:30 AM EDT - 5 months ago

Drug Tariffs Are a Sideshow. Trump's Next Move Could Hit Pharma Harder.

XPH

Big Pharma Unfazed by Trump Tariffs, But Small Biotechs Face Vulnerability

Sep 26, 2025, 2:55 PM EDT - 5 months ago

Big Pharma Unfazed by Trump Tariffs, But Small Biotechs Face Vulnerability

XPH IHE PJP

Trump announces 100% tariffs on pharmaceutical drugs, beginning October 1

Sep 26, 2025, 1:22 PM EDT - 5 months ago

Trump announces 100% tariffs on pharmaceutical drugs, beginning October 1

FTXH IHE XPH

Pharma stocks gain, as Trump's tariff move actually could be a win for the sector

Sep 26, 2025, 1:05 PM EDT - 5 months ago

Pharma stocks gain, as Trump's tariff move actually could be a win for the sector

PJP XPH IHE

PPH: Excellent Pharmaceutical ETF, But Bad Timing To Invest

Sep 18, 2025, 8:52 AM EDT - 5 months ago

PPH: Excellent Pharmaceutical ETF, But Bad Timing To Invest

PPH: Global Pharma Stocks Continue To Face Headwinds, Tariffs Front And Center

Jul 7, 2025, 8:23 PM EDT - 8 months ago

PPH: Global Pharma Stocks Continue To Face Headwinds, Tariffs Front And Center

Healthcare Sector Checkup As U.S. Looks To Change Regulations

May 30, 2025, 3:30 PM EDT - 9 months ago

Healthcare Sector Checkup As U.S. Looks To Change Regulations

AGNG ARKG BBC BBH BBP BIB BIS

Are Your Health Care ETFs Safe? Trump's New Policies May Trigger Shockwaves Across Pharma Stocks

May 8, 2025, 12:08 PM EDT - 10 months ago

Are Your Health Care ETFs Safe? Trump's New Policies May Trigger Shockwaves Across Pharma Stocks

IHE XPH

PPH: Will Overcome Tariffs, But Competitor Funds Look Stronger

Apr 14, 2025, 9:15 AM EDT - 11 months ago

PPH: Will Overcome Tariffs, But Competitor Funds Look Stronger

Seeking Stocks With Vitality In The Volatile Healthcare Sector

Feb 25, 2025, 11:06 AM EST - 1 year ago

Seeking Stocks With Vitality In The Volatile Healthcare Sector

IBB XLV AGNG ARKG BBC BBH BBP

Top 5 Cancer Pharma Stocks With Strong Risk/Reward In 2025

Jan 13, 2025, 6:10 PM EST - 1 year ago

Top 5 Cancer Pharma Stocks With Strong Risk/Reward In 2025

ABBV AMGN AZN BNTX FBCG GILD GSK

Final Trade: MSTR, PPH, TLT, MCD

Jan 7, 2025, 6:37 PM EST - 1 year ago

Final Trade: MSTR, PPH, TLT, MCD

MCD MSTR TLT

Pharma Stocks Losing Ground After A Remarkable Rally, Downgrading PPH

Oct 3, 2024, 12:13 PM EDT - 1 year ago

Pharma Stocks Losing Ground After A Remarkable Rally, Downgrading PPH

PPH: A Strong Fund To Play Big Pharma

Jul 18, 2024, 3:19 PM EDT - 1 year ago

PPH: A Strong Fund To Play Big Pharma

PPH: Buy The Pullback In This Big Pharma ETF For Long-Term Total Returns

Apr 23, 2024, 4:34 AM EDT - 1 year ago

PPH: Buy The Pullback In This Big Pharma ETF For Long-Term Total Returns

PPH: Ignore The Election Scare, Buy Pharma And Healthcare

Jan 19, 2024, 7:03 AM EST - 2 years ago

PPH: Ignore The Election Scare, Buy Pharma And Healthcare

Healthcare In 2024: Navigating The Biopharma Bull Run

Jan 17, 2024, 11:22 PM EST - 2 years ago

Healthcare In 2024: Navigating The Biopharma Bull Run

FHLC IBB IYH VHT XBI XLV

Pharma Is Out of Favor. 5 Drug Stocks With Room to Grow.

Nov 16, 2023, 2:00 AM EST - 2 years ago

Pharma Is Out of Favor. 5 Drug Stocks With Room to Grow.

BMY JNJ LLY PFE

Biotech Stocks Are Rallying, but the Outlook Isn't Good

Nov 15, 2023, 12:28 PM EST - 2 years ago

Biotech Stocks Are Rallying, but the Outlook Isn't Good

XBI XLV

PPH: A 'Shot In The Arm' For Investors Looking To Capitalize On Recent Pharmaceutical Advances

Oct 31, 2023, 3:35 AM EDT - 2 years ago

PPH: A 'Shot In The Arm' For Investors Looking To Capitalize On Recent Pharmaceutical Advances

PPH: GLP-1 Companies And Large-Cap Value Pharma Make For A Compelling Portfolio

Oct 29, 2023, 2:02 AM EDT - 2 years ago

PPH: GLP-1 Companies And Large-Cap Value Pharma Make For A Compelling Portfolio

PPH: Unnecessary Volatility In A Relatively Stable Healthcare Sector (Technical Analysis)

Jul 17, 2023, 2:46 PM EDT - 2 years ago

PPH: Unnecessary Volatility In A Relatively Stable Healthcare Sector (Technical Analysis)

How The Pharmaceutical Industry Is Using AI

May 14, 2023, 3:56 AM EDT - 3 years ago

How The Pharmaceutical Industry Is Using AI

AZN JNJ MSFT NVS

PPH Fell As Much As The Market Despite Resilience

Mar 24, 2023, 3:49 PM EDT - 3 years ago

PPH Fell As Much As The Market Despite Resilience

The Fall Of SVB: What It Means For Healthcare Startups

Mar 16, 2023, 3:51 PM EDT - 3 years ago

The Fall Of SVB: What It Means For Healthcare Startups

BBC BBH FBT IBB IHE IHF IHI

Betting On Biotech

Feb 10, 2023, 10:02 AM EST - 3 years ago

Betting On Biotech

DVA MRNA

PPH Might Be Too Safe For A Recovering Market

Jan 13, 2023, 5:28 PM EST - 3 years ago

PPH Might Be Too Safe For A Recovering Market

Can Health Care Stocks Outperform Again In 2023?

Jan 11, 2023, 6:09 PM EST - 3 years ago

Can Health Care Stocks Outperform Again In 2023?

AGNG ARKG BBC BBH BBP BMED CNCR

StocktwitsNews
StocktwitsNews Feb. 23 at 11:31 AM
Merck Is Reportedly Splitting Its Pharma Division As Keytruda Patent Nears 2028 Expiry $MRK $PPH $PJP $IYH https://stocktwits.com/news/equity/markets/merck-splitting-pharma-division-keytruda-patent-nears-2028-expiry/cZRt85ZR4yE
0 · Reply
chuckieclam
chuckieclam Feb. 23 at 10:16 AM
$NVO $PPH $PVAL $VKTX
0 · Reply
StocktwitsNews
StocktwitsNews Feb. 23 at 9:55 AM
Why Is NVO Stock Falling Pre-Market Today? $NVO $PPH $PVAL $AVDE $FTHI https://stocktwits.com/news/equity/markets/why-is-nvo-stock-falling-pre-market-today/cZRtZlKR4UC
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 20 at 1:13 AM
$PPH Current Stock Price: $110.95 Contracts to trade: $111.0 PPH Feb 20 2026 Call Entry: $0.35 Exit: $0.48 ROI: 38% Hold ~25 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 18 at 9:40 PM
$PPH RSI: 71.14, MACD: 1.8078 Vol: 2.11, MA20: 108.30, MA50: 105.08 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
StocktwitsNews
StocktwitsNews Feb. 12 at 10:21 AM
Novo Looks To Ireland To Scale Production Of Wegovy Pill: Report $NVO $OZEM $PPH https://stocktwits.com/news/equity/markets/novo-looks-to-ireland-to-scale-production-of-wegovy-pill-report/cZRT0F6R4rc
0 · Reply
TalkMarkets
TalkMarkets Feb. 9 at 8:08 PM
Wild Week Of Rotation: Sector Performance 2026 $PPH $SPY $XBI $XLV $ARKG https://talkmarkets.com/content/etfs/wild-week-of-rotation-sector-performance-2026?post=556147
0 · Reply
StocktwitsNews
StocktwitsNews Feb. 9 at 4:21 PM
FDA Says Novo's Wegovy Pill TV Advertisement Is Misleading: NVO Stock Pares Gains $NVO $HIMS $PPH $PVAL $AVDE https://stocktwits.com/news/equity/markets/fda-novo-wegovy-pill-tv-advertisement-misleading-nvo-stock-pares-gains/cZbv5uwR4oX
1 · Reply
StocktwitsNews
StocktwitsNews Feb. 9 at 12:42 PM
Why Did IINN Stock Surge 28% In Pre-Market Today? $IINN $PPH $IHE https://stocktwits.com/news/equity/markets/why-did-iinn-stock-surge-in-pre-market-today/cZbHzC8R4oP
0 · Reply
weqwewqeq1111
weqwewqeq1111 Feb. 9 at 12:37 PM
$NVO $HIMS $PPH $PVAL $AVDE
0 · Reply
StocktwitsNews
StocktwitsNews Feb. 9 at 12:36 PM
Novo Nordisk Sues Hims & Hers Over Compounded Wegovy, Calls For Permanent Sales Ban: HIMS Stock Tanks $NVO $HIMS $PPH $PVAL $AVDE https://stocktwits.com/news/equity/markets/novo-nordisk-sues-hims-hers-permanent-ban-unapproved-compounded-drugs/cZbHzMjR4o2
0 · Reply
goinbananas
goinbananas Feb. 4 at 5:13 PM
$MRK burning red hot 🔥 had to take 60% off the table today. Still keeping 40% as the PE is still pretty low! $PPH $QQQ $SPY
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 4 at 1:58 AM
$PPH Current Stock Price: $106.14 Contracts to trade: $106.0 PPH Feb 20 2026 Call Entry: $1.90 Exit: $3.19 ROI: 68% Hold ~24 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
StocktwitsNews
StocktwitsNews Jan. 30 at 1:59 PM
KZIA Stock Is Rising Today — What Does Its Data For Nuclear PD-L1 Degrader Show? $KZIA $PPH $IHE https://stocktwits.com/news/equity/markets/kzia-stock-rises-after-kazia-therapeutics-data-for-nuclear-pd-l1-degrader/cmySkShR4SI
0 · Reply
StocktwitsNews
StocktwitsNews Jan. 14 at 12:39 PM
Why Did NRXP Stock Surge 21% Pre-Market Today? $NRXP $IBB $XBI $PPH $IHE https://stocktwits.com/news/equity/markets/why-did-nrxp-stock-surge-pre-market-today/cmULXc2R4eL
0 · Reply
goinbananas
goinbananas Jan. 7 at 3:31 PM
$MRK has been cooking! $PPH $QQQ $SPY
0 · Reply
AlphaBull_10M
AlphaBull_10M Jan. 2 at 2:53 PM
$CORT $PPH $IHE $SPY $QQQ
1 · Reply
AlphaBull_10M
AlphaBull_10M Jan. 2 at 2:52 PM
$CORT 6 average target price of $102 (+171% upside). You gotta have some of this after 50% tumble last week. $PPH $IHE $SPY $QQQ
0 · Reply
AlphaBull_10M
AlphaBull_10M Dec. 31 at 5:33 PM
$CORT 6 analysts gave average target of $127 for 250% upside from current $35 level. That said, after today's news, I'm sure analysts will update their targets in coming days and this will come down, but I'm still thinking it'll be over 100% upside potential. $IHE $XPH $PJP $PPH
0 · Reply
AlphaBull_10M
AlphaBull_10M Dec. 31 at 1:45 PM
$CORT Hitting 52 week low in pre-market. Like to start accumulating near $40 if it can get there. $IHE $XPH $PJP $PPH
0 · Reply
AlphaBull_10M
AlphaBull_10M Dec. 31 at 1:40 PM
$CORT Tanking -35% in premarket on FDA CRL. Price looks attractive but let me first do some more detail study before entering. $IHE $XPH $PJP $PPH
1 · Reply
ZacksResearch
ZacksResearch Dec. 30 at 12:30 PM
$NVO's oral obesity pill just got FDA approval — a game changer in weight-loss drugs! 💊 🌟 First FDA-approved oral GLP-1 pill for chronic weight management in the U.S. 💰 Priced at $149/month, more accessible than injectables 📈 Participants lost 16.6% body weight in trials Discover why $OZEM, $THNR, and $PPH might be the smarter play here 👉 https://www.zacks.com/stock/news/2809629/the-obesity-pill-rush-healthcare-etfs-to-gain-as-fda-nods-to-novo-drug?cid=sm-stocktwits-2-2809629-body-26689&ADID=SYND_STOCKTWITS_TWEET_2_2809629_BODY_26689
0 · Reply